<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Standards, Policies, Protocols, and Regulations for Cell-Based Therapies First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-12">July 12, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kunie</forename><surname>Sakurai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for iPS Cell Research and Application</orgName>
								<orgName type="institution">Kyoto University</orgName>
								<address>
									<addrLine>Sakyo-ku</addrLine>
									<settlement>Shogoin, Kyoto</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Kurtz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charit é-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Glyn</forename><surname>Stacey</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">National Institute for Biological Standards and Control</orgName>
								<orgName type="institution" key="instit2">an Operating Centre of the Medicines and Healthcare Products Regulatory Agency</orgName>
								<address>
									<addrLine>South Mimms</addrLine>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Sheldon</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">Human Genetics Institute of New Jersey</orgName>
								<address>
									<settlement>Rutgers</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">The State University of New Jersey</orgName>
								<address>
									<settlement>Piscataway</settlement>
									<region>New Jersey</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Ph.D</roleName><forename type="first">Wataru</forename><surname>Fujibuchi</surname></persName>
							<email>fujibuchi-g@cira.kyoto-u.ac.jp</email>
							<affiliation key="aff0">
								<orgName type="department">Center for iPS Cell Research and Application</orgName>
								<orgName type="institution">Kyoto University</orgName>
								<address>
									<addrLine>Sakyo-ku</addrLine>
									<settlement>Shogoin, Kyoto</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Center for iPS Cell Research and Application</orgName>
								<orgName type="institution">Kyoto University</orgName>
								<address>
									<addrLine>53 Kawahara-cho, Sakyo-ku</addrLine>
									<postCode>606-8507</postCode>
									<settlement>Shogoin, Kyoto</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Standards, Policies, Protocols, and Regulations for Cell-Based Therapies First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-12">July 12, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">A98CB3419B6B4623D0C7C1724938083C</idno>
					<idno type="DOI">10.5966/sctm.2015-0393</idno>
					<note type="submission">Received December 13, 2015; accepted for publication April 18, 2016;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Stem cells x Information sharing x Biological specimen banks x Standards x Regenerative medicine x Quality control</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Advances in stem cell research have triggered scores of studies in regenerative medicine in a large number of institutions and companies around the world.</s><s>However, reproducibility and data exchange among laboratories or cell banks are constrained by the lack of a standardized format for experiments.</s><s>To enhance information flow in stem cell and derivative cell research, here we propose a minimum information standard to describe cellular assay data to facilitate practical regenerative medicine.</s><s>Based on the existing Minimum Information About a Cellular Assay, we developed Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), which allows for the description of advanced cellular experiments with defined taxonomy of human cell types.</s><s>By using controlled terms, such as ontologies, MIACARM will provide a platform for cellular assay data exchange among cell banks or registries that have been established at more than 20 sites in the world.</s><s>STEM CELLS TRANSLATIONAL MEDICINE 2016;5:1345-1361</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SIGNIFICANCE</head><p><s>Currently, there are more than 20 human cell information storage sites around the world.</s><s>However, reproducibility and data exchange among different laboratories or cell information providers are usually inadequate or nonexistent because of the lack of a standardized format for experiments.</s><s>This study, which is the fruit of collaborative work by scientists at stem cell banks and cellular information registries worldwide, including those in the U.S., the U.K., Europe, and Japan, proposes new minimum information guidelines, Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), for cellular assay data deposition.</s><s>MIACARM is intended to promote data exchange and facilitation of practical regenerative medicine.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>The invention of human embryonic stem (hES) cells in 1998 <ref type="bibr" target="#b0">[1]</ref>, followed by human induced pluripotent stem (hiPS) cells in 2007 <ref type="bibr" target="#b1">[2]</ref>, have spearheaded new developments in regenerative medicine around the world.</s><s>A number of large-scale initiatives have been funded to make research-and clinicalgrade hES and hiPS cell resources widely available to the global community <ref type="bibr" target="#b2">[3]</ref>.</s><s>Before clinical application, however, quality checks must be carried out to prove that artificially generated pluripotent stem cells and their differentiated cells can be used to form the basis for safe and effective cell therapies.</s><s>To control the quality of engineered cells, assay data must be comparable to those of naturally existing cells in a defined format.</s></p><p><s>The data accumulation or exchange format must be capable of handling advanced experimental techniques with higher resolutions.</s><s>Recently, next-generation sequencing techniques, in addition to use in the analysis of genome variation and the presence of virus sequences, are being applied to transcriptome and methylome analyses.</s><s>In addition, cellular assays often demand single-cell resolution for quality checks.</s><s>Indeed, it has been reported that, even in cells extracted from a single colony, the derivative cultures may remain heterogeneous, which may well have an impact on cell fate <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b5">[5]</ref><ref type="bibr" target="#b7">[6]</ref><ref type="bibr" target="#b8">[7]</ref>.</s></p><p><s>The accumulation of cellular assay data from pluripotent stem cells and their derivatives has already begun in iPS or embryonic stem (ES) cell banks and registries around the world.</s><s>Cellular information gathered by cell banks is available to the general public.</s><s>In contrast, cell registries collect cellular information from cell banks or laboratories and provide digital information through retrieval systems.</s><s>Fifteen well-known stem cell banks and registries are listed in Table <ref type="table" target="#tab_0">1</ref>.</s><s>The largest numbers of reported hES or hiPS cells for normal and diseased cells are 1,229 at the Human Induced Pluripotent Stem Cells Initiative (HipSci, http://www.hipsci.org) in the U.K. and 373 at the International Stem Cell Registry of University of Massachusetts Medical School in the U.S. (http://www.iscr-admin.com),</s><s>respectively.</s></p><p><s>However, reproducibility and data exchange among cell banks or laboratories are compromised because of the lack of a standardized format for experiments.</s><s>In order to exchange or integrate cellular assay information produced at different sites, not only measurement data, but also the format of additional experimental metadata, such as experimental design, sample information, measurement techniques, measurement uncertainty, etc., must be registered and rendered retrievable.</s><s>The more metadata that are collected, the more precisely cellular assay experiments that are reproduced.</s><s>However, this approach will generate a complex and redundant format, as well as require much space and time for curation.</s><s>For the efficient collection of necessary information, it is vital to clarify minimum, yet indispensable, items for structuring the data format by which cellular assay data can be efficiently stored.</s></p><p><s>To solve this problem, Minimum Information (MI) Standards were invented as reporting guidelines for standardizing data entities.</s><s>The first of such guidelines, Minimum Information About a Microarray Experiment, was organized by international consortia and established to integrate microarray data from various platforms <ref type="bibr" target="#b9">[8]</ref>.</s><s>It was followed by the Minimum Information About a Biomedical or Biological Investigation project in 2008 <ref type="bibr" target="#b10">[9]</ref>, which yielded approximately 80 MIs for various kinds of biological assays.</s><s>Because those guidelines usually target simple phenomena in biological systems, several MIs may have to be combined to function as guidelines for holistic descriptions of cellular systems.</s></p><p><s>As the first attempt to enhance exchangeability of cellular assay data, Minimum Information About a Cellular Assay (MIACA) was created in 2008 as a reporting format that mainly focused on describing functional research using cell lines <ref type="bibr" target="#b11">[10]</ref>.</s><s>However, it was not designed to describe human somatic cells or advanced technologies for single-cell analysis.</s><s>Moreover, for it to be applicable to regenerative medicine, experimental items must comply with existing drug and medical regulations.</s><s>By reorganizing and extending MIACA, we developed Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), which would allow for the description of advanced cellular experiments with defined taxonomy of human cell types.</s></p><p><s>In Figure <ref type="figure" target="#fig_1">1</ref>, a conceptual view of how MIACARM contributes to stem cell research is shown.</s><s>Our aim is to provide information of assays and data of all source cell types (somatic and engineered cells) at the clinical level, by which regenerative medicine and drug discovery can be conducted efficiently.</s><s>In regenerative medicine research, there exists Minimal Information About T Cell Assays <ref type="bibr" target="#b13">[11]</ref> for cell therapy and Bone/Cartilage Tissue Engineering Ontology <ref type="bibr" target="#b14">[12]</ref> for tissue engineering, whereas in drug discovery, there exists Minimum Information required for a Drug Metabolizing Enzymes and Transporters Experiment [13] and Minimum Information About a Bioactive Entity <ref type="bibr" target="#b16">[14]</ref>.</s><s>However, important prerequisite information is lacking in these MIs, including how source cells, such as stem or differentiated cells, are generated by in vitro reprogramming or (trans)differentiation methods, as well as detailed characteristics of the source cells.</s><s>In cases where the information does exist, it is described in free-text format.</s><s>Recently, many research groups have been working on creating organoids for disease modeling, drug screening, and damaged tissue repair <ref type="bibr" target="#b17">[15]</ref>.</s><s>However, organoids present variability in their qualities, and, therefore, it is critical to check the detailed characteristics of the source cells.</s><s>MIACARM plays an important role in ensuring that all safety and efficacy information is available for actual medical situations by providing a list of items to exclude ambiguously described assays and clarify data for cellular quality and safety evaluation.</s></p><p><s>By using controlled terms, such as ontologies, MIACARM can provide a platform for cellular assay data exchange among cell banks, registries, or databases that have been established at more than 20 laboratories or institutes around the world (Kurtz et al., manuscript in preparation).</s><s>The first call for MIACARM was made at the 2014 Mainz Symposium, "Cell-Focused Data: Integration, Organization and Applications," and the present paper contains the first proposal to establish such a system.</s><s>We expect that continuous international efforts will result in the further improvement of MIACARM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Two Levels and Four Layers in MIACARM</head><p><s>We developed two levels of guidelines, MIACARM-I and -II.</s><s>MIACARM-I is the guideline for omics assays in basic research using human cells; MIACARM-II is the guideline for practical regenerative medicine.</s><s>Each guideline consists of a four-layered structure: modules, sections, subsections, and items, from top to bottom.</s><s>Both guidelines will basically contribute to the exchange, maintenance, and reproducibility of cellular assay data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Development of MIACARM Based on MIACA: Five Modules and 15 Sections</head><p><s>We first reorganized the existing cellular assay guideline, MIACA <ref type="bibr" target="#b11">[10]</ref>, and then developed a five-module structure consisting of Project, Source Cell, Assay, Experimental Technology, and Data (Fig. <ref type="figure" target="#fig_0">2</ref>) as the top layer, based on the structure design of the Gene Expression Omnibus (GEO) database <ref type="bibr" target="#b18">[16]</ref>, which consists of three modules: Series, Sample, and Platform.</s><s>We further divided Series of GEO into Project and Assay, and Sample of GEO into Source Cell and Data, to describe both the experimental protocols and information of the cells in greater detail in MIACARM.</s><s>MIACARM consists of 257 items, which are summarized and categorized in supplemental online Table <ref type="table" target="#tab_0">1</ref>.</s><s>As an extension of the MIACA structure, we also added four new sections to the source cell module to MIACARM.</s></p><p><s>In MIACARM-I, we added subsections for Sequencing and Marker Imaging Technology, which are absent in MIACA, to the Experimental Technology module to enable the description of current cell analysis devices.</s><s>We also added two subsections to the Source Cell module, Cell Taxonomy and Anatomical Location.</s><s>In MIACARM-II, we further added two more sections, Stem Cell Production and Stem Cell Quality Control, to the Source Cell module, according to two publications on stem cell banking <ref type="bibr" target="#b19">[17,</ref><ref type="bibr">18]</ref> and four regulations for products from (stem) cells or tissues in Japan, the U.S., and Europe <ref type="bibr">[19]</ref><ref type="bibr">[20]</ref><ref type="bibr" target="#b22">[21]</ref><ref type="bibr" target="#b23">[22]</ref>.</s><s>To describe a single assay, a set of four modules-Assay, Source Cell, Experimental Technology, and Data-are required for reproducibility.</s><s>Therefore, a single project module may contain one or more sets of the four modules to register multiple assays.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ontology Assignment</head><p><s>To control proper curation terms in MIACARM, we collected and assigned necessary IDs and technical and ontological terms from 13 existing collections: BioAssay Ontology <ref type="bibr" target="#b24">[23]</ref>; Cell: Expression, Localization, Development, Anatomy <ref type="bibr" target="#b26">[24]</ref>; Chemical Entities of Biological Interest Ontology <ref type="bibr" target="#b27">[25]</ref>; Cell Ontology <ref type="bibr" target="#b28">[26]</ref>; EDAM Bioinformatics Operations, Data Types, Formats, Identifiers, and Topics <ref type="bibr" target="#b29">[27]</ref>; Experimental Factor Ontology <ref type="bibr" target="#b30">[28]</ref>; Biological Imaging Methods Ontology <ref type="bibr" target="#b32">[29]</ref>; Foundational Model of Anatomy <ref type="bibr" target="#b33">[30]</ref>; Medical Subject Headings <ref type="bibr" target="#b34">[31]</ref>; Microarray and Gene Expression Data Ontology <ref type="bibr" target="#b35">[32]</ref>; National Cancer Institute Thesaurus [33]; Ontology for Biomedical Investigations <ref type="bibr" target="#b36">[34]</ref>; Uber Anatomy Ontology <ref type="bibr" target="#b38">[35]</ref>; and PubMed/MEDLINE [36].</s></p><p><s>Sakurai, Kurtz, <ref type="bibr">Stacey et al. 1347</ref> The assignment of those IDs and terms to the five modules and sections is summarized in supplemental online Table <ref type="table" target="#tab_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of MIACARM</head><p><s>To evaluate how MIACARM reflects a realistic situation, we checked for overlapping items in two sections of MIACARM-II, Stem Cell Production and Stem Cell Quality Control, with the web items used by the 11 stem cell banks and registries listed in Table <ref type="table" target="#tab_0">1</ref>: Stem Cell Bank of Barcelona and Human Pluripotent Stem Cell Registry in the European Union; HipSci, and U.K. Stem Cell Bank in the U.K.; California Institute for Regenerative Medicine, the New York Stem Cell Foundation, the University of Massachusetts International Stem Cell Registry, Rutgers University Cell and DNA Repository Infinite Biologics, and WiCell in the U.S.; and Stemcell Knowledge and Information Portal and RIKEN BioResource Center in Japan.</s><s>Descriptive items for cellular information provided by each website were collected, and unique terms were computationally selected by using the XML library in R statistical language (https://www.</s><s>r-project.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Enhancement of Data Exchange and Comparability Among Different Assays by MIACARM</head><p><s>MIACARM is designed to exchange assay information among different experimental techniques.</s><s>In particular, the new fivemodule structure makes it easier to understand assays at the level of materials and methods than does the three-module structure in MIACA.</s><s>As shown in Figure <ref type="figure" target="#fig_2">3</ref>, we separate Reagent, Instrument, and Cell Line from the subsection (Bio) Materials in the Header module of MIACA and combine them with the Experimental Modules of MIACA to generate the new Experimental Technology module in MIACARM.</s><s>By this reorganization, material information and method information become independent, and any experimental combination of Source Cell and Experimental Technology can be produced, which enhances understanding of the whole experimental process.</s><s>Similarly, the    would have to be retrieved from both the Header and Experimental Modules in MIACA.</s><s>Figure <ref type="figure" target="#fig_3">4</ref> shows how experiments such as transcriptome, methylome, and marker assays are exchangeable and comparable.</s><s>Overall, the new five-module structure is user-oriented, because it makes searching for assays consisting of various combinations of source cells and experimental methods easy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MIACARM-II: Minimum Information for Stem Cell Research</head><p><s>Various cell banks that generate and establish stem cell lines have been launched worldwide.</s><s>Cell registries that accumulate digital information from those cell banks have been established as well (Table <ref type="table" target="#tab_0">1</ref>).</s><s>However, major issues regarding the workability of the cell banks exist and are as follows: (a) there has been no consensus on the quality evaluation of artificially generated stem cells <ref type="bibr" target="#b19">[17,</ref><ref type="bibr">18]</ref>, and, thus, (b) no standardized method is available for establishing the highest-quality stem cells <ref type="bibr" target="#b40">[37,</ref><ref type="bibr" target="#b41">38]</ref>.</s><s>A method for checking whether the established stem cells are of research or clinical grade is still under discussion, although an international consensus on key issues for the establishment of human pluripotent stem cell banks has been published <ref type="bibr" target="#b42">[39]</ref>.</s><s>Even more problematic is the fact that there are no minimum information standards for describing the qualitative or quantitative characteristics of established stem cells <ref type="bibr" target="#b43">[40,</ref><ref type="bibr" target="#b44">41]</ref>, which hampers comparisons between cell lines established in different banks or laboratories.</s></p><p><s>Considering this situation, we first collected items to describe the production procedures and quality checks of stem cells for the "Source cell" module on the basis of six documents for the proper management of cells <ref type="bibr" target="#b19">[17]</ref><ref type="bibr">[18]</ref><ref type="bibr">[19]</ref><ref type="bibr">[20]</ref><ref type="bibr" target="#b22">[21]</ref><ref type="bibr" target="#b23">[22]</ref> (Materials and Methods).</s><s>Among those items, we selected 144 items that are required to assess product quality, safety, and efficacy, as indicated by the international guidelines for medicines established in Japan, the U.S., and Europe <ref type="bibr">[42]</ref>.</s><s>Table <ref type="table" target="#tab_1">2</ref> shows the list of necessary items selected, reference numbers, adoption status by stem cell banks and registries, and MIACARM levels.</s><s>The items are divided into five categories: (a) produced stem cell summary, (b) ethical operation, (c) material, (d) cell banking process, and (e) cell characterization and sterility testing.</s></p><p><s>Upon checking whether each of the 144 items is adopted by the 11 stem cell banks and registries, we found that sterility testing is adopted by most of the stem cell banks and registries.</s><s>However, many items considered important in practical medicine, such as human leukocyte antigen type, single nucleotide polymorphism (SNP), tumorigenesis, etc., are not open to the general public, probably because of privacy issues.</s><s>Furthermore, information required for regulatory compliance for manufacture of regenerative medicines, such as source cell information, culture conditions, culture protocol, etc., are generally missing.</s><s>Importantly, we also found four items necessary for stem cell information registration in which the reference is missing (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Those four items are stem cell ID, date (stem cells) placed in storage, subjected ethical approvals and accrediting agencies involved, and reprogramming type in the stem cell establishment process.</s><s>From the biobanking and repository perspective, it is critically important to use widely available short tandem repeat (STR) or SNPTrace assays to unambiguously document the identity of each biospecimen (source cell, hiPS cells, differentiated cell lines, etc.) to address potential sample mislabeling or swaps that can occur during sample collection and processing <ref type="bibr" target="#b45">[43]</ref>.</s><s>Instances of such errors, which can have profound and costly adverse effects on research studies, are well documented <ref type="bibr" target="#b47">[44]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Validating Items in MIACARM-II As Minimum Information</head><p><s>To evaluate the selected minimum items in MIACARM-II, each item in Table <ref type="table" target="#tab_1">2</ref> is scored by counting the numbers of source references and stem cell banks that adopted it.</s><s>The results are shown in Figure <ref type="figure" target="#fig_7">5</ref>. Red lines indicate an arbitrary 20% threshold of acceptance of items by either source references or stem cell banks, and the four areas separated by the two lines are labeled I-IV clockwise from the top left.</s><s>The numbers of items in areas I-IV are 18, 50, 75, and 1, respectively.</s><s>When we examined the independences of the item distributions by Pearson's x 2 test with Yates' continuity correction using chisq.test</s><s>function in statistical computing language R, we found a probability of 2.6 3 10 25 that was significantly low, and the probabilities of the standardized residuals for all areas were also significant (i.e., areas I and III contain larger numbers of items, and areas II and IV contain smaller numbers of items).</s><s>In area II, the items that received high scores from both source references and stem cell banks are important in many fields of stem cell research and application.</s><s>Items in area I received high scores from stem cell banks and included attributes associated with stem cell materials, such as Stem Cell Name, Contact Information of Provider/Distributor (Distribution Bank), and biological information of source cell donor, such as Gender of Donor, Age of Donor When Source Cell Was Obtained, and Informed Consent From Donor.</s><s>In particular, all six items with high scores in box "a" are used for database management rather than for describing the safety or quality of the materials, including Stem Cell ID, Stem Cell Name, Contact Information of Generator, and Provider/Distributor (Distribution Bank).</s><s>It is noteworthy that most items are distributed in area III, where high scores are received from source references, and are mainly about experimental materials used in the stem cell culture and establishment.</s><s>The three items in box b, which received the highest scores from source references, comprise two items, Basal Medium and Culture Additive and Concentration, related to the culture conditions of the source cells, and, more important, one item, Copy Number Variation (CNV), which cannot be provided from the raw data provided by stem cell banks because of privacy issues.</s><s>Only HipSci provides sanitized CNV data by scatter plot.</s><s>Finally, in area IV, which is the least supported by source references and stem cell banks, we observed only one item, Single Nucleotide Polymorphisms (SNPs), in MIACARM that considers cancer risks <ref type="bibr" target="#b48">[45,</ref><ref type="bibr" target="#b49">46]</ref> as safety information for stem cells used as clinical products.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>We propose for the first time a minimum information standard to describe cellular assay data for the facilitation of practical regenerative medicine.</s><s>This proposal was made on the basis of the presentations delivered at the 2014 Mainz Symposium, "Cell-Focused Data: Integration, Organization and Applications," and serves as a starting point for promoting international contributions toward its further development.</s><s>Based upon the existing MIACA, we developed MIACARM, which is expected</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Related Efforts and Paths to Optimize Minimum Guidelines</head><p><s>Currently, there are more than 20 human cell information storage sites, such as banks, registries, and databases, in the world.</s><s>However, reproducibility and data exchange among different laboratories or cell information storages are usually inadequate or nonexistent because of the lack of a standardized format for experiments.</s><s>Moreover, the standardization of cell-quality evaluations in relation to regenerative medicine products is still under discussion.</s><s>Despite the launch of the first clinical trial based on iPS cells in Japan in 2014 <ref type="bibr" target="#b50">[47]</ref>, subsequent actions following that study have been delayed, reflecting caution toward patient treatment.</s><s>This delay is expected given the current lack of standards for cell preparation and assessment and little experience in stem cell therapies.</s><s>MIACARM is expected to contribute to the development of comparative standards.</s><s>Because MIACARM was developed on the basis of proposals and regulations in Japan, the U.S., and Europe-the three jurisdictions involved in development standards under the International Consensus on Harmonization-we expect it to mature and become a consensus guideline that reflects practice of and advances in regenerative medicine.</s><s>Another effort for the standardization of stem cell  research is the development of stem cell and cell line nomenclature <ref type="bibr" target="#b43">[40,</ref><ref type="bibr" target="#b51">[48]</ref><ref type="bibr" target="#b52">[49]</ref><ref type="bibr" target="#b53">[50]</ref>.</s><s>Such nomenclature would be integrated into MIACARM as a unique cell type name descriptor, which would reduce errors and confusion about the cells used in any experiments.</s></p><p><s>Recently, the draft "Guidelines for Stem Cell Science and Clinical Translation" was proposed by the International Society for Stem Cell Research [51].</s><s>However, this draft proposes guidelines toward establishing regulatory rules.</s><s>Conversely, discussions with stem cell experts are needed to determine the items required for inclusion in MIACARM as "minimum" mandatory information and a framework drafting for standardization issues from cell banking to the manufactured regenerative medicine product proposed by Stacey (2014) <ref type="bibr" target="#b54">[52]</ref>.</s><s>To optimize MIACARM, we need to organize international conventions on a periodic basis that draw consensus from a broader range of experts involved in world stem cell bank registries.</s><s>We should also bring MIACARM to the attention of the International Organization of Standardization, currently beginning to develop approaches to standards in regenerative medicine manufacturing, and the Organisation for Economic Co-operation and Development which is currently developing a new standard for good in vitro methodology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flexibility to Incorporate Newly Developed Techniques and Increasing Number of Cell Types</head><p><s>We have also developed a human cell repository database called SHOGoiN (formerly CELLPEDIA <ref type="bibr" target="#b55">[53]</ref>), where we curate gene expression data in a defined format using the MIACARM guideline.</s><s>Recently, more advanced experimental techniques at single-cell resolution, including transcriptome, methylome, proteome, etc., have been reported.</s><s>For example, the single-cell mass cytometry assay can identify 18 types of hematopoietic cells on the basis of surface antigens <ref type="bibr" target="#b56">[54]</ref>.</s><s>To enter those data, MIACARM must have sufficient flexibility to incorporate newly developed techniques.</s></p><p><s>In addition, unidentifiable or new cell types have been found by single-cell analysis <ref type="bibr" target="#b58">[55]</ref>.</s><s>Therefore, MIACARM must be sufficiently flexible to deal with the continuously increasing number of cell types.</s></p><p><s>In the future, an extended MIACARM would be required for more precise description of other important cellular assays based on stem cells, such as disease modeling, drug discovery, tissue engineering, etc.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p><s>One important issue to be resolved is how to handle and store massive cell data.</s><s>By using single-cell barcode technology, thousands of cells are analyzed at one time to measure omics data <ref type="bibr" target="#b59">[56]</ref>.</s><s>We expect to encounter millions of cell omics measurement data, from which we need to retrieve only necessary information for particular cell types.</s><s>To resolve the massive cell data handling and storage issue, new computational systems, such as distributed or cloud-type databases, are proposed by bio-database sites in the world <ref type="bibr">[57]</ref><ref type="bibr" target="#b60">[58]</ref><ref type="bibr" target="#b61">[59]</ref>.</s><s>However, such distributed database systems require not only time and funding, but also an international cooperation by a large number of consenting researchers (Kurtz et al., manuscript in preparation).</s><s>In any case, extended MIACARM or completely new cellular assay guidelines would be needed to support such systems in the coming big data era.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Basic structure of MIACARM: five modules and two levels (I and II).</s><s>By reorganizing the three-module structure of MIACA, we adopted a five-module structure in MIACARM.</s><s>MIACARM-I contains the guideline for basic research, which includes omics assays using human cells.</s><s>MIACARM-II contains the guideline for practical regenerative medicine, which includes terms related to cell quality checks.</s><s>Abbreviations: MIACA, Minimum Information About a Cellular Assay; MIACARM, Minimum Information About a Cellular Assay for Regenerative Medicine; NGS, next-generation sequencing; QC, quality control.</s></p></div></figDesc><graphic coords="4,54.29,386.49,229.46,175.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>MIACARM enhances quality of stem cell research.</s><s>In practical medicine, such as drug discovery, cell therapy, tissue engineering, etc., based on stem cells or their derivatives, MIACARM provides a procedure for source cell production and source cell quality and safety information to existing MIs.</s><s>Abbreviations: BCTEO, Bone/Cartilage Tissue Engineering Ontology; DMET, Drug Metabolizing Enzymes and Transporters; iPS, induced pluripotent stem; MI, minimum information; MIABE, Minimum Information About a Bioactive Entity; MIACA, Minimum Information About a Cellular Assay; MIACARM, Minimum Information About a Cellular Assay for Regenerative Medicine; MIATA, Minimal Information About T Cell Assays; MIDE, Minimum Information Required for a Drug Metabolizing Enzymes and Transporters Experiment.</s></p></div></figDesc><graphic coords="4,130.85,186.45,108.02,108.26" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Differences in modules and sections between MIACA and MIACARM.</s><s>In contrast to the three-module structure in MIACA, a fivemodule structure in MIACARM was developed to enhance the understanding of assays at the materials and methods level.</s><s>Abbreviations: MIACA, Minimum Information About a Cellular Assay; MIACARM, Minimum Information About a Cellular Assay for Regenerative Medicine; PI, principal investigator.</s></p></div></figDesc><graphic coords="5,131.47,78.22,322.31,284.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Example of exchangeability and comparability of transcriptome, methylome, and marker assays.</s><s>The five-module structure (Project module is not shown) makes it easy to search for various combinations of cell materials and experimental methods.</s><s>Abbreviations: iPS, induced pluripotent stem; MIACARM, Minimum Information About a Cellular Assay for Regenerative Medicine; RT-PCR, reverse-transcription polymerase chain reaction.</s></p></div></figDesc><graphic coords="5,131.33,419.01,322.70,225.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Checklist for stem cell production and QC items in the Source Cell module in MIACARM-II</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>[</head><label></label><figDesc><div><p></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>a) the description of advanced cellular experiments with defined taxonomy of human cell types and controlled terms (MIACARM-I), and (b) the description of production procedures and quality checks of stem cells (MIACARM-II).</s><s>MIACARM is expected to provide a platform for cellular assay data exchange among cell banks or registries around the world.</s><s>Furthermore, we anticipate several important regulatory advantages by adopting MIACARM: (a) deposition of the minimum information and assay metadata to reduce missing and unnecessary information about the cells, (b) progress toward reproducible experiments, and (c) retrieval by omnibus search across all cell banks and registries in the world.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Evaluation of items in Minimum Information About a Cellular Assay for Regenerative Medicine II (MIACARM-II).</s><s>Items in MIA-CARM-II are scored by counting the numbers of source references on the basis of data in Table 2. Red lines indicate 20% threshold of acceptance by either source references or stem cell banks.</s></p></div></figDesc><graphic coords="15,327.17,78.81,203.18,196.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Examples of stem cell banks and registries (as of October 14, 2015) Abbreviations: ALS, amyotrophic lateral sclerosis; B, bank; BLCB, Stem Cell Bank of Barcelona; BRC, BioResource Center; CIRM, California Institute for Regenerative Medicine; CRM, Center for Regenerative Medicine; EBiSC, European Bank for Induced Pluripotent Stem Cells; EU, European Union; hES, human embryonic stem; hiPSC, human induced pluripotent stem cell; HipSci, Human Induced Pluripotent Stem Cells Initiative; hPSCreg, Human Pluripotent Stem Cell Registry; iPSC, induced pluripotent stem cell; JP, Japan; NIMH, National Institute of Mental Health; NINDS, National Institute of Neurological Disorders and Stroke; NYSCF, New York Stem Cell Foundation; R, registry; RUCDR, Rutgers University Cell and DNA Repository Infinite Biologics; SKIP, Stemcell Knowledge and Information Portal; TBA, to be announced; UMass ISCR, University of Massachusetts International Stem Cell Registry.</s></p></div></figDesc><table><row><cell>Country</cell><cell>Bank or registry</cell><cell>Stem cell bank or registry</cell><cell>No. of hES/hiPSC entries</cell><cell>Website</cell></row><row><cell>EU</cell><cell>B</cell><cell>BLCB</cell><cell>Normal: 33</cell><cell>http://www.cmrb.eu/</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>banco-lineas-celulares</cell></row><row><cell></cell><cell>R</cell><cell>hPSCreg</cell><cell>Normal: 730</cell><cell>http://hpscreg.eu</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 58</cell><cell></cell></row><row><cell>U.K.</cell><cell>R</cell><cell>HipSci</cell><cell>Normal: 1229</cell><cell>http://www.hipsci.org</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 207</cell><cell></cell></row><row><cell></cell><cell>B</cell><cell>U.K. Stem Cell Bank</cell><cell>Normal: 23 (approved</cell><cell>http://www.nibsc.org</cell></row><row><cell></cell><cell></cell><cell></cell><cell>research grade: 100; approved</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>clinical grade: 41)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 1</cell><cell></cell></row><row><cell></cell><cell>B</cell><cell>EBiSC</cell><cell>TBA</cell><cell>http://www.ebisc.org</cell></row><row><cell>U.S.</cell><cell>R</cell><cell>CIRM</cell><cell>Normal: 48</cell><cell>https://www.cirm.ca.gov/</cell></row><row><cell></cell><cell>B</cell><cell>Coriell Institute</cell><cell>Diseased: 300</cell><cell>https://catalog.coriell.org/1/</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Stem-Cells</cell></row><row><cell></cell><cell>B</cell><cell>Harvard Stem Cell Institute</cell><cell>Normal: 23</cell><cell>http://stemcelldistribution.</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 3</cell><cell>harvard.edu</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Status unknown: 29</cell><cell></cell></row><row><cell></cell><cell>R</cell><cell>NIH Stem Cell Database</cell><cell>Normal: 21</cell><cell>https://stemcelldb.nih.gov/</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>public.do</cell></row><row><cell></cell><cell>B</cell><cell>NYSCF</cell><cell>Normal: 73</cell><cell>http://nyscf.org</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 113</cell><cell></cell></row><row><cell></cell><cell>R</cell><cell>UMass ISCR</cell><cell>Normal: 1135</cell><cell>http://www.iscr-admin.com</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 373</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Abnormal karyotype: 65</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Status unknown: 12</cell><cell></cell></row><row><cell></cell><cell>B</cell><cell>RUCDR Infinite Biologics</cell><cell>Normal: 25</cell><cell>http://www.rucdr.org</cell></row><row><cell></cell><cell></cell><cell>NIMH Stem Cell Center</cell><cell>Diseased: 332</cell><cell>https://www.nimhgenetics.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>org/stem_cells</cell></row><row><cell></cell><cell></cell><cell>NINDS Human Cell and Data</cell><cell></cell><cell>https://bioq.nindsgenetics.</cell></row><row><cell></cell><cell></cell><cell>Repository</cell><cell></cell><cell>org</cell></row><row><cell></cell><cell></cell><cell>NIH CRM iPSC Collection</cell><cell></cell><cell>http://www.nimhgenetics.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>org/stem_cells/crm_lines.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>php</cell></row><row><cell></cell><cell></cell><cell>Target ALS Foundation</cell><cell></cell><cell>http://www.targetals.org</cell></row><row><cell></cell><cell>B</cell><cell>WiCell Research Institute</cell><cell>Normal: 69</cell><cell>http://www.wicell.org</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 2</cell><cell></cell></row><row><cell>JP</cell><cell>B</cell><cell>RIKEN BRC Cell Bank</cell><cell>Normal: 16</cell><cell>http://cell.brc.riken.jp/en</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 320</cell><cell></cell></row><row><cell></cell><cell>R</cell><cell>SKIP</cell><cell>Normal: 137</cell><cell>http://www.skip.med.keio.</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Diseased: 367</cell><cell>ac.jp/en</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Status unknown: 152</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Others: 6</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell>19-22]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell>1354</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="15">Minimum Information Guidelines for Stem Cell Banks</cell></row><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>CIRM NYSCF UMass ISCR</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Source documents</cell><cell>[18-22]</cell><cell></cell><cell>[18-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell></cell><cell>[19-22]</cell><cell>[19-22]</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[19-22]</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell></row><row><cell></cell><cell></cell><cell>Item</cell><cell>Coating substrate name</cell><cell>(if used)</cell><cell>Feeder cell name (if</cell><cell>used)</cell><cell>Feeder cell seeding</cell><cell>density (if used)</cell><cell>Feeder cell preparation</cell><cell>protocol (if used)</cell><cell>Synthesized basement</cell><cell>membrane name (if</cell><cell>used)</cell><cell>Nanofiber name (if used)</cell><cell>Bead name (if used)</cell><cell>Names of other materials</cell><cell>(if used)</cell><cell>Safety and sterility</cell><cell>descriptions of</cell><cell>materials/agents used</cell><cell>Materials used for culture</cell><cell>in final step of stem cell</cell><cell>production</cell><cell>Basal medium</cell><cell>Basal medium vendor</cell><cell>and lot no.</cell><cell>Culture additive and</cell><cell>concentration</cell><cell>Antibiotic name and</cell><cell>concentration (if used)</cell><cell>Coating substrate name</cell><cell>(if used)</cell><cell>Feeder cell name (if</cell><cell>used)</cell><cell>Feeder cell seeding</cell><cell>density (if used)</cell><cell>Feeder cell preparation</cell><cell>protocol</cell></row><row><cell cols="7">©AlphaMed Press 2016</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell cols="8">Sakurai, Kurtz, Stacey et al.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1355</cell></row><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>NYSCF UMass ISCR CIRM</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Source documents</cell><cell>[19-22]</cell><cell></cell><cell></cell><cell>[19-22]</cell><cell>[19-22]</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[19, 20, 22]</cell><cell></cell><cell>[19, 20]</cell><cell></cell><cell>[19, 20, 22]</cell><cell></cell><cell>[19, 20]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[19-21]</cell><cell></cell><cell>[19-21]</cell><cell></cell><cell>[19, 20]</cell><cell></cell><cell>[19, 20]</cell><cell></cell><cell>[19, 20]</cell><cell></cell><cell>[19, 20]</cell></row><row><cell></cell><cell></cell><cell>Item</cell><cell>Synthesized basement</cell><cell>membrane name (if</cell><cell>used)</cell><cell>Nanofiber name (if used)</cell><cell>Bead name (if used)</cell><cell>Names of other materials</cell><cell>(if used)</cell><cell>Safety and sterility</cell><cell>descriptions of</cell><cell>materials/agents used</cell><cell>Materials used for stem cell</cell><cell>storage and transfer/</cell><cell>shipping</cell><cell>Stem cell storage/</cell><cell>banking media</cell><cell>Stem cell storage/</cell><cell>banking container</cell><cell>Stem cell transferring/</cell><cell>shipping media</cell><cell>Stem cell transferring/</cell><cell>shipping container</cell><cell>(packing)</cell><cell>Cell banking process</cell><cell>Source cell procurement</cell><cell>process</cell><cell>Source cell procurement</cell><cell>protocol</cell><cell>Source cell transferring</cell><cell>container</cell><cell>Source cell transferring</cell><cell>method</cell><cell>Source cell transferring</cell><cell>protocol</cell><cell>Source cell storage/</cell><cell>banking media</cell><cell>Source cell storage/</cell><cell>master cell banking</cell><cell>method</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell>1356</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="14">Minimum Information Guidelines for Stem Cell Banks</cell></row><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>CIRM UMass ISCR NYSCF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s s s</cell><cell>s</cell><cell></cell><cell>s s</cell><cell>s s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Source documents</cell><cell>[19, 20]</cell><cell></cell><cell></cell><cell>[17-20]</cell><cell></cell><cell>[17-20]</cell><cell></cell><cell></cell><cell></cell><cell>[17, 19]</cell><cell>[17, 19]</cell><cell>[17-19]</cell><cell></cell><cell>[17-19]</cell><cell></cell><cell></cell><cell>-a</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell>[19-22]</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell></row><row><cell></cell><cell></cell><cell>Item</cell><cell>Source cell storage/</cell><cell>master cell banking</cell><cell>protocol</cell><cell>Material transferring</cell><cell>method</cell><cell>Material transferring</cell><cell>protocol</cell><cell>QC for source cell culture</cell><cell>conditions</cell><cell>Culture temperature</cell><cell>% O 2 concentration in air</cell><cell>% CO 2 concentration</cell><cell>in air</cell><cell>Passage protocol</cell><cell>Stem cell establishment</cell><cell>process</cell><cell>Reprogramming type</cell><cell>Transgene name and</cell><cell>amount</cell><cell>Vector type</cell><cell>Virus type</cell><cell>Transgene induction</cell><cell>method</cell><cell>Transgene induction</cell><cell>efficiency</cell><cell>Protein name and</cell><cell>amount</cell><cell>Protein induction</cell><cell>method</cell><cell>Protein induction</cell><cell>efficiency</cell><cell>Small molecule name</cell><cell>and concentration</cell><cell>Small molecule induction</cell><cell>method</cell></row><row><cell cols="7">©AlphaMed Press 2016</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="11">STEM CELLS TRANSLATIONAL MEDICINE</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell cols="8">Sakurai, Kurtz, Stacey et al.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1357</cell></row><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell><cell></cell><cell>II</cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>CIRM NYSCF UMass ISCR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell><cell>s</cell><cell></cell><cell>s</cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Source documents</cell><cell>[19-22]</cell><cell></cell><cell>[19-22]</cell><cell></cell><cell></cell><cell>[19-22]</cell><cell></cell><cell></cell><cell>[19, 21]</cell><cell>[19, 21, 22]</cell><cell>[19-21]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[17, 19]</cell><cell>[17, 19]</cell><cell>[17-19]</cell><cell></cell><cell>[19]</cell><cell>[17-19]</cell><cell></cell><cell></cell><cell>[17, 19-22]</cell><cell></cell><cell>[17, 19-22]</cell><cell></cell><cell>[17, 19-22]</cell><cell></cell><cell></cell><cell>[17, 19-22]</cell><cell></cell><cell></cell><cell>[17, 18]</cell></row><row><cell></cell><cell></cell><cell>Item</cell><cell>Original provider of</cell><cell>molecule</cell><cell>Procurement of</cell><cell>molecule (molecule</cell><cell>preparation method)</cell><cell>Establishment protocol</cell><cell>(molecular induction</cell><cell>protocol)</cell><cell>Cell population purity</cell><cell>In-process control used</cell><cell>Intermediate product</cell><cell>cell information (if</cell><cell>existing)</cell><cell>QC for stem cell culture</cell><cell>conditions</cell><cell>Culture temperature</cell><cell>% O 2 concentration in air</cell><cell>% CO 2 concentration</cell><cell>in air</cell><cell>Culture protocol</cell><cell>Passage protocol</cell><cell>QC for stem cell storage/</cell><cell>banking conditions</cell><cell>Stem cell storage/</cell><cell>banking protocol</cell><cell>Stem cell density for</cell><cell>storage/banking</cell><cell>Stem cell</cell><cell>cryopreservation/</cell><cell>freezing method</cell><cell>Stem cell</cell><cell>cryopreservation/</cell><cell>cooling temperature</cell><cell>Stem cell</cell><cell>cryopreservation</cell><cell>cryoprotectant</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell>II</cell><cell></cell><cell></cell><cell>II</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>II</cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell>s</cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>CIRM NYSCF UMass ISCR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Source documents</cell><cell>[18, 19]</cell><cell></cell><cell></cell><cell>[17, 19-22]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[17, 18, 20]</cell><cell>[18, 20]</cell></row><row><cell></cell><cell></cell><cell>Item</cell><cell>Stem cell</cell><cell>cryopreservation/</cell><cell>cooling rate</cell><cell>Stem cell storage/</cell><cell>banking condition</cell><cell>Stem cell QC</cell><cell>Cell characterization and</cell><cell>sterility testing</cell><cell>Stem cell characteristics</cell><cell>Population doublings</cell><cell>Crisis population</cell><cell>doubling level</cell><cell>Viability at thawing</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Cont'd)Stem Cell Bank of Barcelona; BRC, BioResource Center; CIRM, California Institute for Regenerative Medicine; CNV, copy number variation; HipSci, Induced Pluripotent Stem Cells Initiative; HLA, human leukocyte antigen; hPSCreg, European Human Pluripotent Stem Cell Registry; MIACARM, Minimum Information About a Cellular Assay for Regenerative Medicine; NYSCF, New York Stem Cell Foundation; QC, quality control; RUCDR, Rutgers University Cell and DNA Repository Infinite Biologics; SKIP, Stemcell Knowledge and Information Portal; SNP, single nucleotide polymorphism; STR, short tandem repeat; U.K. SCB, U.K. Stem Cell Bank; UMass ISCR, University of Massachusetts International Stem Cell Registry.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Covered by MIACARM</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell></cell><cell>II</cell><cell>II</cell><cell>II</cell></row><row><cell></cell><cell>JP</cell><cell>RIKEN BRC</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>SKIP</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>WiCell</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>RUCDR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Stem cell bank and registry</cell><cell>U.S.</cell><cell>CIRM NYSCF UMass ISCR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell></row><row><cell></cell><cell>U.K</cell><cell>U.K. SCB</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>HipSci</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>EU</cell><cell>hPSCreg</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell></row><row><cell></cell><cell></cell><cell>BLCB</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell>s</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Item Source documents</cell><cell>QC for sterility of stem cell</cell><cell>Bacterial contamination [17-22]</cell><cell>(sterility test)</cell><cell>Fungal contamination [17-22]</cell><cell>(sterility test)</cell><cell>Mycoplasma [17-22]</cell><cell>contamination</cell><cell>Protozoal contamination [17-22]</cell><cell>Viral contamination [17, 19-22]</cell><cell>Other sterility test [17, 22]</cell><cell>a Items appear in the listed 11 stem cell registries.</cell><cell>Abbreviations: BLCB,</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.StemCellsTM.com   ©AlphaMed Press 2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We thank the participants of the workshop, "Cell-focused data: integration, organization and applications," held in</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head><p><s>K.S.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript; A.K., G.S., and M.S.: provision of study material or patients, final approval of manuscript; W.F.: conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST</head><p><s>The authors indicated no potential conflicts of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Embryonic stem cell lines derived from human blastocysts</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Itskovitz-Eldor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Shapiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="1145" to="1147" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</title>
		<author>
			<persName><forename type="first">K</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohnuki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="861" to="872" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper</title>
		<author>
			<persName><forename type="first">Fac</forename><surname>Soares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sheldon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cell Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="931" to="939" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hemberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barahona</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Transcriptome-wide noise controls lineage choice in mammalian progenitor cells</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">453</biblScope>
			<biblScope unit="page" from="544" to="547" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Atabay</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Single-cell analysis reveals transcriptional heterogeneity of neural progenitors in human cortex</title>
	</analytic>
	<monogr>
		<title level="j">Nat Neurosci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="637" to="646" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Narsinh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sanchez-Freire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1217" to="1221" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Rinkevich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Walmsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page">2151</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Minimum information about a microarray experiment (MIAME)-toward standards for microarray data</title>
		<author>
			<persName><forename type="first">A</forename><surname>Brazma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hingamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Quackenbush</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="365" to="371" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Promoting coherent minimum reporting guidelines for biological and biomedical investigations: The MIBBI project</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-A</forename><surname>Sansone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="889" to="896" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Wiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mehrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hahne</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main">MIACA-minimum information about a cellular assay, and the cellular assay object model</title>
		<ptr target="http://miaca.sourceforge.net.Accessed" />
		<imprint>
			<date type="published" when="2015-10-15">October 15. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">MIATA&quot;-minimal information about T cell assays</title>
		<author>
			<persName><forename type="first">S</forename><surname>Janetzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Britten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="527" to="528" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Guidelines for managing data and processes in bone and cartilage tissue engineering</title>
		<author>
			<persName><forename type="first">F</forename><surname>Viti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Scaglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Orro</surname></persName>
		</author>
		<idno>S14. 13</idno>
		<ptr target="http://mibbi.sourceforge.net/projects/MIDE.shtml.Accessed" />
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2014-10-15">2014. October 15. 2015</date>
		</imprint>
	</monogr>
	<note>Minimum information required for a DMET experiment</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Minimum Information Guidelines for Stem Cell Banks ©AlphaMed Press 2016 STEM CELLS TRANSLATIONAL MEDICINE</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Minimum information about a bioactive entity (MIABE)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Orchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Al-Lazikani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bryant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="661" to="669" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The boom in mini stomachs, brains, breasts, kidneys and more</title>
		<author>
			<persName><forename type="first">C</forename><surname>Willyard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">523</biblScope>
			<biblScope unit="page" from="520" to="522" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">NCBI GEO standards and services for microarray data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Edgar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barrett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1471" to="1472" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">19 Pharmaceutical and Food Safety Bureau, Evaluation and Licensing Division, Ministry of Health, Labour and Welfare. Guideline to complete the application form for ensuring the quality and safety of pharmaceuticals and medical devices based on cells or tissue</title>
		<author>
			<persName><forename type="first">G</forename><surname>Stacey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Brain Res</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="page" from="301" to="314" />
			<date type="published" when="2009">2012. 2009</date>
		</imprint>
	</monogr>
	<note>18 International Stem Cell Banking Initiative. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. in Japanese</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">20 Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. Guideline on ensuring the quality and safety of human allogeneic induced pluripotent stem (-like) cells-derived medical devices or pharmaceuticals</title>
		<author>
			<persName><surname>Yakushokushinsa-Hatsu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">No. 0420-1, 2010</date>
		</imprint>
	</monogr>
	<note>in Japanese</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><surname>Yakushoku-Hatsu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">No. 0907-4, 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Committee for Advanced Therapies. Reflection paper on stem cell-based medicinal products</title>
	</analytic>
	<monogr>
		<title level="j">European Medical Agency</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Draft guidance for industry: Potency tests for cellular and gene therapy products</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">S</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">D</forename><surname>Vempati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Przydzial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chung</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)</title>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e49198</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">CELDA-an ontology for the comprehensive representation of cells in complex systems</title>
		<author>
			<persName><forename type="first">S</forename><surname>Seltmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stachelscheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Damaschun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">228</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The ChEBI reference database and ontology for biologically relevant chemistry: Enhancements for 2013</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hastings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Matos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dekker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="D456" to="D463" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Logical development of the cell ontology</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Meehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Masci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abdulla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">EDAM: An ontology of bioinformatics operations, types of data and identifiers, topics and formats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalaš</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jonassen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1325" to="1332" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Malone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holloway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Adamusiak</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Modeling sample variables with an experimental factor ontology</title>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1112" to="1118" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Available at http://cellimagelibrary.org. Accessed</title>
	</analytic>
	<monogr>
		<title level="j">Biological Imaging Methods Ontology</title>
		<imprint>
			<date type="published" when="2015-10-15">2015. October 15. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A reference ontology for biomedical informatics: The Foundational Model of Anatomy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rosse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jlv</forename><surname>Mejino</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biomed Inform</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="478" to="500" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Beyond synonymy: Exploiting the UMLS semantics in mapping vocabularies</title>
		<author>
			<persName><forename type="first">O</forename><surname>Bodenreider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Hole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc AMIA Symp</title>
		<imprint>
			<biblScope unit="page" from="815" to="819" />
			<date type="published" when="1998">1998. 1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The MGED Ontology: A resource for semantics-based description of microarray experiments</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Whetzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Parkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Causton</surname></persName>
		</author>
		<ptr target="http://ncit.nci.nih.gov.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="866" to="873" />
			<date type="published" when="2006-10-15">2006. October 15. 2015</date>
		</imprint>
	</monogr>
	<note>33 National Cancer Institute Thesaurus</note>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Brinkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Courtot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Derom</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Modeling biomedical experimental processes with OBI</title>
	</analytic>
	<monogr>
		<title level="j">J Biomed Semantics</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">S7</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mungall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Torniai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Gkoutos</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Uberon, an integrative multi-species anatomy ontology</title>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">R5</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">An efficient nonviral method to generate integrationfree human-induced pluripotent stem cells from cord blood and peripheral blood cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Okita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsumura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">STEM CELLS</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="458" to="466" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Senda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">3594</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Benvinisty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regen Med</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">A call for standardized naming and reporting of human ESC and iPSC lines</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Luong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Auerbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Crook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="357" to="359" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">42 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. The international guidelines for medicines</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Litterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ekins</surname></persName>
		</author>
		<ptr target="http://www.ich.org/home.html.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Drug Discov Today</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="247" to="254" />
			<date type="published" when="2015-10-15">2015. October 15. 2015</date>
		</imprint>
	</monogr>
	<note>Databases and collaboration require standards for human stem cell research</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Human biosample authentication using the highthroughput, cost-effective SNPtrace(TM) system</title>
		<author>
			<persName><forename type="first">Mmy</forename><surname>Liang-Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Haverty</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0116218</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Cell line misidentification: The beginning of the end</title>
		<author>
			<persName><forename type="first">C</forename><surname>Alston-Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="441" to="448" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Single-nucleotide polymorphism (SNP) analysis to associate cancer risk</title>
		<author>
			<persName><forename type="first">J</forename><surname>Earl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Greenhalf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="volume">576</biblScope>
			<biblScope unit="page" from="171" to="196" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Functional annotation of colon cancer risk SNPs</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>Tak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Berman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">5114</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Japan stem-cell trial stirs envy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Reardon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cyranoski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">513</biblScope>
			<biblScope unit="page" from="287" to="288" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The nomenclature system should be sustainable, but also practical</title>
		<author>
			<persName><forename type="first">H</forename><surname>Higashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Brüstle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Q</forename><surname>Daley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="606" to="607" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">hPSCreg-the human pluripotent stem cell registry</title>
		<author>
			<persName><forename type="first">S</forename><surname>Seltmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lekschas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Müller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="D757" to="D763" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">51 International Society For Stem Cell Research. Guidelines for stem cell science and clinical translation draft</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Selvaraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mmy</forename><surname>Liang-Chu</surname></persName>
		</author>
		<ptr target="http://www.isscr.org/docs/default-source/hesc-guidelines/isscr-draft-guidelines-for-stem-cell-science-and-clinical-translation.pdf?sfvrsn=2.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">520</biblScope>
			<biblScope unit="page" from="307" to="311" />
			<date type="published" when="2015-06-26">2015. June 26. 2015. 2015. October 15. 2015</date>
		</imprint>
	</monogr>
	<note>A resource for cell line authentication, annotation and quality control</note>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">The challenge of standardisation in stem cell research and development</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Stacey</surname></persName>
		</author>
		<editor>Ilic D</editor>
		<imprint>
			<date type="published" when="2014">2014</date>
			<publisher>Springer</publisher>
			<biblScope unit="page" from="11" to="18" />
			<pubPlace>New York, NY</pubPlace>
		</imprint>
	</monogr>
	<note>Stem cell banking</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">CELL-PEDIA: A repository for human cell information for cell studies and differentiation analyses</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hatano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Moesa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Database</title>
		<imprint>
			<biblScope unit="page">46</biblScope>
			<date type="published" when="2011">2011. 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Bendall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Simonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Qiu</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum</title>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">332</biblScope>
			<biblScope unit="page" from="687" to="696" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zeisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Muñoz-Manchado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Codeluppi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="1138" to="1142" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Highly multiplexed and strand-specific singlecell RNA 59 end sequencing</title>
		<author>
			<persName><forename type="first">S</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kjällquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moliner</surname></persName>
		</author>
		<ptr target="http://lifesciencedb.jp/" />
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="813" to="828" />
			<date type="published" when="2012-10-15">2012. Accessed October 15. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Big data from small data: Data-sharing in the &apos;long tail&apos; of neuroscience</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Ferguson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Nielson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Cragin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1442" to="1447" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">The National Institutes of Health&apos;s Big Data to Knowledge (BD2K) initiative: Capitalizing on biomedical big data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Derr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dunn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Inform Assoc</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="957" to="958" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<monogr>
		<title level="m">StemCellsTM.com for supporting information available online</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<monogr>
		<title/>
		<author>
			<persName><surname>Sakurai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stacey</forename><surname>Kurtz</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
